Skip to content
Research/Peptides/Nandrolone

Nandrolone

Anabolic steroid for joint and tissue support

Intelligence Profile

Clinical Applications

Nandrolone is being investigated for several therapeutic applications, though clinical evidence remains limited and findings are mixed.

Sarcopenia and Muscle Wasting

The most established clinical use of nandrolone is for sarcopenia treatment. One ongoing Phase 2 trial (NCT05978206) is evaluating nandrolone combined with physiotherapy and dietary interventions for sarcopenia management. The anabolic properties of nandrolone may help preserve or restore muscle mass in patients experiencing age-related or disease-related muscle loss.

Cancer-Related Malnutrition

Nandrolone has been studied for treating malnutrition in cancer patients. A completed clinical trial (NCT03263520) investigated its impact on cancer-induced malnutrition, though specific outcomes from this study are not detailed in the available evidence. The rationale likely stems from nandrolone's potential to stimulate appetite and promote weight gain in wasting conditions.

Telomeropathies

An interesting application emerged from a completed Phase 1/2 trial (NCT02055456) examining nandrolone decanoate for treating telomeropathies - rare genetic disorders affecting telomere function. This represents a novel therapeutic approach, though the mechanism and efficacy data are not provided in the current evidence.

Safety Considerations

Available research highlights several safety concerns:

  • Liver toxicity: Animal studies demonstrate that nandrolone decanoate can cause liver injury, though protective effects of certain compounds (like cumin oil) have been investigated
  • Reproductive effects: Prepubertal exposure studies in animals show alterations in testicular structure and spermatogenic function
  • Neurological effects: Research suggests supraphysiological doses may not provide additional benefits for brain plasticity markers

Evidence Limitations

The clinical evidence for nandrolone remains limited. Most therapeutic applications are still in early-phase trials or have completed studies without published results. The available research consists primarily of animal studies and case reports rather than large-scale human clinical trials. Healthcare providers should carefully weigh potential benefits against documented risks when considering nandrolone therapy.

This information is for educational purposes only and should not replace professional medical advice. Consult with a healthcare provider before considering any nandrolone-based treatment.

Free account required

Clinical data requires a free AXIFI account to access clinical data, safety profiles, and research papers.